Last reviewed · How we verify
Assessment of Hyperkalemia's Illness and Treatment Burden in Chronic Kidney Disease and Heart Failure Patients: HK Registry Pilot Study (HKRegistrypilo)
Overall study aim of this study is to analyse descriptive statistics of Patient-Reported Outcome（PROs） which will be used in the Hyperkalemia（HK） registry study in hyperkalemia patients with Chronic Kidney Disease（CKD） or Heart Failure（HF） to describe the practice patterns of hyperkalemia treatment in in clinical practice. Based on these assessments, this study will provide the information for the applicability of PRO measurements which will be used in the Hyperkalemia registry study to the study population, i.e. CKD and/or HF patients with hyperkalemia
Details
| Lead sponsor | AstraZeneca |
|---|---|
| Status | COMPLETED |
| Enrolment | 146 |
| Start date | Fri Jul 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Hyperkalemia
Countries
Japan